unknown
Stage
1
Investors
About
Angitia Bio is a clinical-stage biotechnology company developing innovative biologic therapies for serious musculoskeletal diseases, including osteoporosis and osteogenesis imperfecta.
Explore Angitia Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.